{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:55:32Z","timestamp":1793778932463,"version":"4.6.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"am","delay-in-days":398,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.humpath.2024.105697","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T22:13:37Z","timestamp":1732054417000},"page":"105697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: Diagnostic overlaps and defining features"],"prefix":"10.1016","volume":"156","author":[{"given":"Ashley K.","family":"Volaric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-2908","authenticated-orcid":false,"given":"Yuri","family":"Fedoriw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2024.105697_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.humpath.2024.105697_bib2","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.humpath.2024.105697_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006890","article-title":"Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming na\u00efve B cells, and facilitates recruitment of transcription factors to the viral genome","volume":"14","author":"Szymula","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.humpath.2024.105697_bib4","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of epstein-barr virus-induced disease","author":"Taylor","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.humpath.2024.105697_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.humpath.2024.105697_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-pathmechdis-012418-013023","article-title":"Epstein-barr virus and cancer","volume":"14","author":"Farrell","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/his.14379","article-title":"The role of EBV in haematolymphoid proliferations: emerging concepts relevant to diagnosis and treatment","volume":"79","author":"Ababneh","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2024.105697_bib8","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.3390\/cancers13205189","article-title":"Epstein\u2013barr virus\u2014associated malignancies and immune escape: the role of the tumor microenvironment and tumor cell evasion strategies","volume":"13","author":"Bauer","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2024.105697_bib9","doi-asserted-by":"crossref","unstructured":"Ozturk V, Yikilmaz AS, Kilicarslan A, Bakanay SM, Akinci S, Dilek Imdat. The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma. Clin Lymphoma, Myeloma & Leukemia n.d.;20:375\u2013381. https:\/\/doi.org\/10.1016\/j.clml.2019.11.021.","DOI":"10.1016\/j.clml.2019.11.021"},{"key":"10.1016\/j.humpath.2024.105697_bib10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.7555\/JBR.28.20140066","article-title":"T cells expressing a LMP1-specific chimeric antigen receptor mediate antitumor effects against LMP1-positive nasopharyngeal carcinoma cells in vitro and in vivo","volume":"28","author":"Tang","year":"2014","journal-title":"Journal of Biomedical Research"},{"key":"10.1016\/j.humpath.2024.105697_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.semdp.2018.02.001","article-title":"Reexamining post-transplant lymphoproliferative disorders: newly recognized and enigmatic types","volume":"35","author":"Aguilera","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib12","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood-2018-04-842559","article-title":"Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?","volume":"132","author":"Natkunam","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105697_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hon.751","article-title":"Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis","volume":"23","author":"Capello","year":"2005","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.humpath.2024.105697_bib14","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.humpath.2024.105697_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13040899","article-title":"Analysis of post-transplant lymphoproliferative disorder (PTLD) outcomes with epstein\u2013barr virus (EBV) assessments\u2014a single tertiary referral center experience and review of literature","volume":"13","author":"Lau","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2024.105697_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/pin.12745","article-title":"EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: single center series of nine cases","volume":"69","author":"Satou","year":"2019","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2024.105697_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22031053","article-title":"Epstein\u2013barr virus-positive mucocutaneous ulcer: a unique and curious disease entity","volume":"22","author":"Ikeda","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2024.105697_bib18","series-title":"International Agency for Research on Cancer","article-title":"Haematolymphoid tumours","year":"2022"},{"key":"10.1016\/j.humpath.2024.105697_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","article-title":"New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders","volume":"482","author":"Quintanilla-Martinez","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2024.105697_bib20","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international Consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105697_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.semdp.2021.04.004","article-title":"Rare EBV-associated B cell neoplasms of the gastrointestinal tract","volume":"38","author":"Volaric","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/oxfordjournals.annonc.a058617","article-title":"Hodgkin's disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors","volume":"4","author":"Andrieu","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2024.105697_bib23","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/1097-0142(19940501)73:9<2400::AID-CNCR2820730925>3.0.CO;2-C","article-title":"Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid","volume":"73","author":"Rubio","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2024.105697_bib24","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","article-title":"HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era","volume":"30","author":"Montoto","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2024.105697_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12185-012-1127-5","article-title":"Clinical characteristics of human immunodeficiency virus-associated Hodgkin lymphoma patients in Japan","volume":"96","author":"Yotsumoto","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.humpath.2024.105697_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.semdp.2016.11.003","article-title":"Cutaneous EBV-related lymphoproliferative disorders","volume":"34","author":"Gru","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11912-005-0062-5","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation","volume":"7","author":"Teruya-Feldstein","year":"2005","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.humpath.2024.105697_bib28","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/s41379-020-0599-8","article-title":"Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer","volume":"33","author":"Ikeda","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1978::AID-CNCR23>3.0.CO;2-P","article-title":"The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant","volume":"82","author":"Chadburn","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2024.105697_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3960\/jslrt.18039","article-title":"A review of EBV-positive mucocutaneous ulcers focusing on clinical and pathological aspects","volume":"59","author":"Ikeda","year":"2019","journal-title":"J Clin Exp Hematop : JCEH"},{"key":"10.1016\/j.humpath.2024.105697_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcp\/aqw214","article-title":"EBV-Positive B-cell proliferations of varied malignant potential","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib32","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/PAS.0000000000001271","article-title":"Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors","volume":"43","author":"Kurita","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib33","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105697_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAS.0000000000000954","article-title":"Cancer therapy-associated lymphoproliferative disorders: an under-recognized type of immunodeficiency-associated lymphoproliferative disorder","volume":"42","author":"Pina-Oviedo","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib35","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1097\/TP.0000000000001767","article-title":"The immune response to Epstein barr virus and implications for posttransplant lymphoproliferative disorder","volume":"101","author":"Martinez","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.humpath.2024.105697_bib36","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(06)67933-6","article-title":"Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study","volume":"367","author":"Webber","year":"2006","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.humpath.2024.105697_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, epstein-barr virus infection, and disease in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.humpath.2024.105697_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer-A study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.oooo.2012.04.003","article-title":"Epstein-Barr virus-positive mucocutaneous ulcer of the oral cavity: the importance of having a detailed clinical history to reach a correct diagnosis","volume":"114","author":"Attard","year":"2012","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"},{"key":"10.1016\/j.humpath.2024.105697_bib40","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/his.13464","article-title":"Comparison of Epstein-Barr virus-positive mucocutaneous ulcer associated with treated lymphoma or methotrexate in Japan","volume":"72","author":"Daroontum","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2024.105697_bib41","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11899-020-00594-1","article-title":"Immunodeficiency-related lymphoid proliferations: new insights with relevance to practice","volume":"15","author":"Bhavsar","year":"2020","journal-title":"Current Hematol. Malig. Rep."},{"key":"10.1016\/j.humpath.2024.105697_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2011.03.003","article-title":"Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients","volume":"305","author":"Cesarman","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.humpath.2024.105697_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcp\/aqw214","article-title":"EBV-positive B-cell proliferations of varied malignant potential: 2015 SH\/EAHP workshop report-Part 1","volume":"147","author":"Natkunam","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib44","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/PAS.0000000000001661","article-title":"EBV-Positive mucocutaneous ulcer with small lymphocytic infiltration mimicking nonspecific ulceration","volume":"45","author":"Fujimoto","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/bjh.15614","article-title":"Diagnosis of Hodgkin lymphoma in the modern era","volume":"184","author":"Wang","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2024.105697_bib46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pathol.2019.09.005","article-title":"Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis","volume":"52","author":"Piris","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2024.105697_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.27470","article-title":"Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management","author":"Ansell","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2024.105697_bib48","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients","volume":"13","author":"Oyama","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2024.105697_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ajcp\/aqw216","article-title":"B-cell and classical Hodgkin lymphomas associated with immunodeficiency: 2015 SH\/EAHP workshop report-Part 2","volume":"147","author":"de Jong","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib50","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder","volume":"38","author":"Hart","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAS.0000000000001186","article-title":"The spectrum of EBV-positive mucocutaneous ulcer","volume":"43","author":"Prieto-Torres","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2024.152344","article-title":"Targeted mutational profiling of Epstein Barr virus-positive mucocutaneous ulcer: implications for differential diagnosis with EBV-positive diffuse large B-cell lymphoma","volume":"73","author":"Volaric","year":"2024","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5644\/ama2006-124.329","article-title":"Classic Hodgkin lymphoma - old disease, new directions: an update on pathology, molecular features and biological prognostic markers","volume":"50","author":"Perry","year":"2021","journal-title":"Acta Med Acad"},{"key":"10.1016\/j.humpath.2024.105697_bib54","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2015-02-630632","article-title":"EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment","volume":"126","author":"Nicolae","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105697_bib55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/his.13197","article-title":"Reappraisal of Epstein\u2013Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells","volume":"71","author":"Ohashi","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2024.105697_bib56","doi-asserted-by":"crossref","unstructured":"Stuhlmann-Laeisz C, Szczepanowski M, Borchert A, Br\u00fcggemann M, Klapper W. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra-and peritumoral B-cells with activated Epstein-Barr virus n.d. https:\/\/doi.org\/10.1007\/s00428-014-1661-z.","DOI":"10.1007\/s00428-014-1661-z"},{"key":"10.1016\/j.humpath.2024.105697_bib57","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/modpathol.2011.62","article-title":"Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population","volume":"24","author":"Hofscheier","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib58","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/s41379-020-0575-3","article-title":"Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas","volume":"33","author":"Mundo","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib59","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2024.105697_bib60","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","article-title":"Latency and lytic replication in Epstein-Barr virus-associated oncogenesis","volume":"17","author":"M\u00fcnz","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.humpath.2024.105697_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2024.152286","article-title":"Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: diagnostic implications","volume":"70","author":"Volaric","year":"2024","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/PAI.0000000000000568","article-title":"RNA in situ hybridization for epstein-barr virus and cytomegalovirus: comparison with in situ hybridization and Immunohistochemistry","volume":"27","author":"Roe","year":"2019","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2024.105697_bib63","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1699-0463.1994.tb05196.x","article-title":"Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study","volume":"102","author":"Lauritzen","year":"1994","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2024.105697_bib64","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/jcp.2007.050146","article-title":"Contribution of the Epstein\u2013Barr virus to the molecular pathogenesis of Hodgkin lymphoma","volume":"60","author":"Kapatai","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib65","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/modpathol.2012.70","article-title":"Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features","volume":"25","author":"Louissaint","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib66","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1073\/pnas.88.11.4766","article-title":"Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells","volume":"88","author":"Herbst","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2024.105697_bib67","first-page":"13","article-title":"High incidence of Epstein-Barr virus genomes in Hodgkin's disease","volume":"137","author":"Herbst","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2024.105697_bib68","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/pathogens7010028","article-title":"EBV-positive lymphoproliferations of B- T- and NK-cell derivation in non-immunocompromised hosts","volume":"7","author":"Dojcinov","year":"2018","journal-title":"Pathogens"},{"key":"10.1016\/j.humpath.2024.105697_bib69","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/cas.12812","article-title":"Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma","volume":"106","author":"Okamoto","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2024.105697_bib70","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cmi.2015.02.017","article-title":"Epstein-Barr virus (EBV) DNA in whole blood as a superior prognostic and monitoring factor than EBV-encoded small RNA in situ hybridization in diffuse large B-cell lymphoma","volume":"21","author":"Liang","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.humpath.2024.105697_bib71","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2012-09-454694","article-title":"Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial","volume":"121","author":"Kanakry","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2024.105697_bib72","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cam4.2710","article-title":"High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi","volume":"9","author":"Montgomery","year":"2020","journal-title":"Cancer Med"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724002065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817724002065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T21:41:43Z","timestamp":1741297303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817724002065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":72,"alternative-id":["S0046817724002065"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105697","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: Diagnostic overlaps and defining features","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2024.105697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105697"}}